191 related articles for article (PubMed ID: 29512779)
1. Suppression of YAP by DDP disrupts colon tumor progression.
Li K; Guo J; Wu Y; Jin D; Jiang H; Liu C; Qin C
Oncol Rep; 2018 May; 39(5):2114-2126. PubMed ID: 29512779
[TBL] [Abstract][Full Text] [Related]
2. Repression of YAP by NCTD disrupts NSCLC progression.
Guo J; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Li X; Xi S
Oncotarget; 2017 Jan; 8(2):2307-2319. PubMed ID: 27903989
[TBL] [Abstract][Full Text] [Related]
3. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
[TBL] [Abstract][Full Text] [Related]
4. Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway.
Jin D; Wu Y; Shao C; Gao Y; Wang D; Guo J
Oncol Rep; 2018 Aug; 40(2):609-620. PubMed ID: 29901163
[TBL] [Abstract][Full Text] [Related]
5. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients.
Xia Y; Chang T; Wang Y; Liu Y; Li W; Li M; Fan HY
PLoS One; 2014; 9(3):e91770. PubMed ID: 24622501
[TBL] [Abstract][Full Text] [Related]
6. Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation.
Zhou J; Zeng Y; Cui L; Chen X; Stauffer S; Wang Z; Yu F; Lele SM; Talmon GA; Black AR; Chen Y; Dong J
Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6760-E6769. PubMed ID: 29967145
[TBL] [Abstract][Full Text] [Related]
7. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
[TBL] [Abstract][Full Text] [Related]
8. Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines.
Ferraiuolo M; Pulito C; Finch-Edmondson M; Korita E; Maidecchi A; Donzelli S; Muti P; Serra M; Sudol M; Strano S; Blandino G
Cancer Lett; 2018 Oct; 433():18-32. PubMed ID: 29933048
[TBL] [Abstract][Full Text] [Related]
9. miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP.
Choe MH; Yoon Y; Kim J; Hwang SG; Han YH; Kim JS
Cell Death Dis; 2018 May; 9(6):640. PubMed ID: 29844307
[TBL] [Abstract][Full Text] [Related]
10. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway.
Tang X; Sun Y; Wan G; Sun J; Sun J; Pan C
BMC Cancer; 2019 Jul; 19(1):654. PubMed ID: 31269911
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse.
Corvaisier M; Bauzone M; Corfiotti F; Renaud F; El Amrani M; Monté D; Truant S; Leteurtre E; Formstecher P; Van Seuningen I; Gespach C; Huet G
Oncotarget; 2016 Aug; 7(35):56699-56712. PubMed ID: 27527859
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells.
Zhou X; Su J; Feng S; Wang L; Yin X; Yan J; Wang Z
Oncotarget; 2016 Nov; 7(48):79076-79088. PubMed ID: 27738325
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
[TBL] [Abstract][Full Text] [Related]
15. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
Ma L; Cui J; Xi H; Bian S; Wei B; Chen L
Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609
[TBL] [Abstract][Full Text] [Related]
16. Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway.
Zhang Y; Yuan J; Zhang X; Yan F; Huang M; Wang T; Zheng X; Zhang M
Oncol Rep; 2016 Dec; 36(6):3619-3626. PubMed ID: 27779692
[TBL] [Abstract][Full Text] [Related]
17. YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma.
Yang C; Tan J; Zhu J; Wang S; Wei G
Oncotarget; 2017 Jun; 8(23):37154-37163. PubMed ID: 28415761
[TBL] [Abstract][Full Text] [Related]
18. Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.
Kuo CC; Ling HH; Chiang MC; Chung CH; Lee WY; Chu CY; Wu YC; Chen CH; Lai YW; Tsai IL; Cheng CH; Lin CW
Theranostics; 2019; 9(9):2526-2540. PubMed ID: 31131051
[No Abstract] [Full Text] [Related]
19. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma.
Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H
Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049
[TBL] [Abstract][Full Text] [Related]
20. Yes-associated protein (YAP) expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma.
Wang S; Li H; Wang G; Zhang T; Fu B; Ma M; Quan Z; Chen G
Clin Transl Oncol; 2016 Feb; 18(2):172-7. PubMed ID: 26254048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
